schliessen

Filtern

 

Bibliotheken

2.

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.
by Antonia, Scott J

The New England journal of medicine, December 13, 2018, Vol.379(24), pp.2342-2350

3.

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
by Antonia, Scott J

The New England journal of medicine, November 16, 2017, Vol.377(20), pp.1919-1929

6.

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
by Antonia, Scott J. 2017

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer. New England Journal of Medicine, 377(20), 1919-1929., United States. (2017).

2017
7.

Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers.
by Peters, Solange

Clinical cancer research : an official journal of the American Association for Cancer Research, January 1, 2019, Vol.25(1), pp.64-72

13.

Agranulocytosis Induced by Vancomycin. Case Report and Literature Review.
by Di Fonzo, Horacio

The American journal of case reports, September 3, 2018, Vol.19, pp.1053-1056

12

Recommended databases

Find more Articles matching your search terms in these recommended databases.

Filter electronic articles 37 Hits